The BvgAS two-component system is the master regulator of virulence gene expression in the mammalian pathogens Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. This paper reports the partial cloning and characterization of the bvgAS loci of the 'new' Bordetella species Bordetella holmesii, Bordetella trematum and Bordetella hinzii, which are increasingly recognized as opportunistic pathogens in humans. It is demonstrated that the cytoplasmic signalling domains of the BvgS histidine kinases of B. pertussis and B. holmesii are functionally interchangeable, while signal perception by the two sensor proteins seems to be different. Furthermore, it is shown that, despite the high similarity of the BvgA proteins of B. pertussis and B. holmesii, promoter recognition by the response regulator proteins differs substantially in these organisms.
INTRODUCTION
The members of the genus Bordetella form a group of closely related organisms. With the exception of Bordetella petrii, which was recently isolated from river sediment , Bordetella species so far have been found exclusively in close association with host organisms (Cotter & DiRita, 2000; Gerlach et al., 2001 ). The so-called 'classical' Bordetella species include Bordetella pertussis, Bordetella parapertussis, Bordetella bronchiseptica and Bordetella avium. The human pathogens B. pertussis and B. parapertussis are the causative agents of whooping cough and a milder pertussis-like disease, respectively. B. bronchiseptica causes respiratory infections in a wide range of warm-blooded animals and B. avium is the aetiological agent of bordetellosis, an upper respiratory tract disease of young poultry and other birds (Skeeles & Arp, 1988) . The 'classical' Bordetella species are quite well characterized and, with the exception of B. avium, whose genome sequence is in the finishing phase, their genome sequences have already been published (Parkhill et al., 2003) .
Within the past few years, four new species have been added to the genus Bordetella. Bordetella holmesii can cause disease in man and has been isolated from blood cultures of patients with underlying disease and from patients with whooping cough-like symptoms (Weyant et al., 1995; Tang et al., 1998; Yih et al., 1999; Mazengia et al., 2000; Shepard et al., 2004) .
Bordetella hinzii appears to be a commensal of birds, although it has been isolated occasionally also from the blood of immunocompromised patients (Cookson et al., 1994; Kattar et al., 2000) . Bordetella trematum was isolated from patients suffering ear or wound infections, but was not found in the respiratory tract (Vandamme et al., 1996) ; at present its pathogenic potential is not known. Finally, B. petrii was the first member of the genus to be isolated from the environment . Little is known about the biology and the pathogenic potential of these 'new' Bordetella species, although B. holmesii is increasingly recognized as being associated with human disease (Yih et al., 1999) .
highly conserved two-component system encoded by the bvgAS locus (Weiss et al., 1983; Arico et al., 1989; Cotter & DiRita, 2000; ).
BvgAS mediates the transition between the virulent and the avirulent phenotype by two phenomena called antigenic modulation and phase variation. Antigenic modulation describes a reversible on-and-off switch in the expression of pathogenicity factors in response to environmental signals, such as temperature, magnesium sulphate or nicotinic acid, and is caused by changes in the phosphorylation state of the BvgAS two-component system (Lacey, 1960; Uhl & Miller, 1996; Zu et al., 1996; Perraud et al., 1998) . In contrast, phase variation, which occurs in vitro at a straindependent frequency of 10
22
- 10 26 , is characterized by the irreversible loss of expression of the virulence-associated genes irrespective of the growth conditions (Leslie & Gardner, 1931; Peppler, 1982; Peppler & Schrumpf, 1984) . It has been shown in a B. pertussis isolate that phase variation was due to a frameshift mutation in the bvgS gene (Stibitz et al., 1989) , while in B. bronchiseptica, phase variation is frequently caused by small deletions within the bvgS gene .
In contrast to the 'classical' species, virtually nothing is known about virulence-relevant features of the 'new' Bordetella species. Since the BvgAS system is the master regulator of virulence in the 'classical' species, we characterized the orthologous genes from the 'new' species in order to use the BvgAS system as a starting point for the identification of possible virulence factors in these species. In the present paper we describe the properties of the BvgAS systems of the new species, with the main emphasis on the human pathogen B. holmesii.
METHODS
Bacterial strains and growth conditions. Bacterial strains used in this study are listed in Table 1 . B. holmesii strains were grown in brain heart infusion (BHI; Difco) or on Bordet-Gengou (BG) agar plates supplemented with 20 % horse blood (Bordet & Gengou, 1909) . B. pertussis strains were grown in modified Stainer-Scholte medium (Stainer & Scholte, 1970; Aoyama et al., 1986) or on BG agar plates. When required, antibiotics were added to the following final concentrations: streptomycin, 100 mg ml
21
; kanamycin, 25 mg ml 21 ; tetracycline, 12?5 mg ml 21 ; ampicillin, 100 mg ml 21 ; and chloramphenicol, 15 mg ml 21 . Bacterial conjugations were performed as described previously (Gross & Rappuoli, 1988) , using Escherichia coli SM10 as the donor strain (Simon et al., 1983) . Protein lysates were prepared from bacteria grown on BG agar plates for 72 h at 37 uC which were suspended in saline at a cell density of 2?4610 9 c.f.u. ml
.
General techniques. DNA manipulation, cloning procedures and SDS-PAGE were carried out according to standard procedures (Sambrook & Russell, 2000) . PCR amplifications were performed with a model Progene thermocycler (Techne) by using Deep Vent DNA polymerase (New England Biolabs) or Taq polymerase (Qbiogene). All cloned PCR products were subjected to automated sequencing (Big Dye kit; Perkin-Elmer) to ensure proper amplification. Immunoblot analysis was performed using a semidry blotting procedure as described by Towbin et al. (1979) . Membrane-immobilized filamentous haemagglutinin (FhaB) and green fluorescent protein (GFP) were detected using goat FhaB and rabbit GFP antiserum (Invitrogen), respectively.
Characterization of the bvgAS loci of B. holmesii, B. trematum and B. hinzii. PCR reactions with degenerate oligonucleotide primers were performed essentially as described by Morel-Deville et al. (1997) using chromosomal DNA of B. holmesii G7702, B. trematum and B. hinzii as templates. The degenerate primers were deduced from highly conserved regions of the receiver domain and from the output domain of BvgA BP from B. pertussis. Plasmids and oligonucleotides used in this study are listed in Table 1 and Table 2 , respectively.
Primer pair deg1-forward/deg1-reverse was deduced from the sequence motifs IIDD and GAAGF, which correspond to amino acid residues 7-10 and 97-101, respectively, of the BvgA BP receiver domain. Primer pair deg2-forward/deg2-reverse was deduced from the sequence motifs GAAGF and KL(N/G)(G/A), which correspond to amino acids 97-101 in the receiver domain and amino acids [190] [191] [192] [193] in the output domain of BvgA BP , respectively. Using primer pair deg1-forward/deg1-reverse, a fragment of the expected length (285 bp) could be amplified from chromosomal DNA of B. holmesii (BH) and B. hinzii (BHZ), while no PCR product was obtained using chromosomal DNA of B. trematum (BT) as template. Using primer pair deg2-forward/deg2-reverse, PCR fragments 54 bp shorter than the expected ones were amplified from genomic DNA of B. holmesii and B. trematum, while no product was obtained with chromosomal DNA of B. hinzii as template.
The PCR products were cloned into pGEM-T vector DNA, giving rise to plasmids pGEM-T-deg1 BH , pGEM-T-deg1 BHZ , pGEM-T-deg2 BH and pGEM-T-deg2 BT , and sequenced. Sequence analysis demonstrated that the cloned DNA fragments were indeed derived from the bvgA orthologues of the 'new' Bordetella species. Interestingly, primer deg2-reverse turned out to have annealed to a sequence motif within bvgA BH and bvgA BT , which is located further upstream than the motif from which the degenerate primer sequence was derived, therefore yielding PCR fragments of unexpected length.
Partial genomic libraries of B. holmesii were screened using PCR fragment 'deg1 BH ' as probe. The DNA inserts of positive clones were subsequently sequenced to assemble the complete nucleotide sequence of bvgA BH including its flanking DNA regions. termini. This PCR fragment was cloned into pACYC184, and the resulting plasmid was digested with PstI, thereby deleting 354 bp from bvgA BH because of the presence of three PstI restriction sites (at positions 206, 467 and 560 with respect to the bvgA BH start codon) in the bvgA BH gene. Subsequently, a kanamycin-resistance cassette, excised by PstI cleavage from pUC4K, was inserted into the PstI-digested plasmid pACYC-bvgA BH , yielding plasmid pACYCbvgA BH -kan R . The bvgA BH -kan R fragment was excised with BamHI and ligated into the suicide vector pSS1129, giving rise to plasmid pSS1129-bvgA BH -kan R , which was subsequently transformed into E. coli SM10. pSS1129-bvgA BH -kan R was then conjugated into B. holmesii G7702 using E. coli SM10 as donor strain. Allelic exchange resulted in the B. holmesii strain G7702/bvgA : : kan. The correct insertion of the kanamycin-resistance cassette into the bvgA BH gene of the kanamycin-resistant exconjugants was proven by PCR reactions with primers flanking the integration site and by Southern blot analysis.
Construction of B. holmesii and B. pertussis strains containing a plasmid with a fusion of the upstream region of bvgA BH to the gfp reporter gene. A DNA fragment containing the promoterless gfp-mut2 gene (Cormack et al., 1996) was excised with XbaI and PstI from plasmid pKEN and ligated into plasmid pUC18, giving rise to plasmid pUC-gfp. A 455 bp DNA fragment containing the upstream region of the bvgAS BH locus was PCR amplified from genomic DNA of B. holmesii G7702 using primer pair bvgAS BH up-5/bvgAS BH up-3, thereby introducing BamHI and XbaI restriction sites at the 59 and 39 termini, respectively, and the fragment was cloned into pUC-gfp, resulting in plasmid pUCbvgAS BH up-gfp. The bvgAS BH up-gfp fragment was then excised by BamHI-and PstI-digestion and was subsequently ligated into plasmid pMMB208. In the resulting plasmid pMMB-bvgAS BH up-gfp, the bvgAS BH up-gfp promoter fusion is located in the opposite orientation to the plasmid-borne tac promoter. pMMB-bvgAS BH up-gfp was subsequently transformed into E. coli SM10 and transferred by conjugation into various B. holmesii and B. pertussis strains.
Construction of plasmids expressing recombinant BvgA BP , BvgS BP and BvgA BH proteins, and protein purification. The construction of pQE-BvgSTRO and pCYT-BvgA BP has been described by Perraud et al. (1998) . For the generation of plasmid pQE-BvgA BH , a DNA fragment including the complete bvgA BH gene (621 bp) was amplified from genomic DNA of B. holmesii G7702 using primer pair bvgA BH -BamHI/bvgA BH -KpnI, thus introducing BamHI and KpnI sites at its 59 and 39 ends respectively. This PCR fragment was ligated into BamHI/KpnI-digested pQE30 vector DNA, creating an N-terminal His 6 -tag. Recombinant His 6 -BvgA BH and His 6 -BvgS BP , encoded on plasmids pQE-BvgA BH and pQE-BvgSTRO, respectively, were expressed in E. coli M15 cells and the proteins were purified by affinity chromatography on Ni 2+ -nitrilotriacetic acid agarose (Qiagen) essentially as described by Perraud et al. (1998) . Native BvgA BP encoded on plasmid pCYT-BvgA BP was overexpressed in E. coli DH5a cells and the protein was purified by affinity chromatography on heparin-Sepharose CL-6B (Pharmacia) as described by Perraud et al. (1998) . In vitro-phosphorylation assays with the recombinant proteins were performed as described by Bock & Gross (2002) .
Primer extension experiments. Total RNA was prepared from bacteria grown in liquid culture as described previously . Primer extension experiments were carried out essentially as described by with primer oligonucleotides fhaB-PE, bvgA BH -PE and gfp-PE (Table 2) . Sequencing reaction mixtures, with plasmids pSL-bvgAS BH G7702 and pUCbvgAS BH up-gfp as template DNA and the appropriate oligonucleotide primer, were analysed on 6 % urea-polyacrylamide gels and used as standards for determination of the transcription initiation sites.
Gel retardation experiments. A 77 bp DNA fragment encompassing the BvgA BP -P binding site of the fhaB promoter was amplified by PCR using primer pair fhaBup5/fhaBup3 and plasmid pProm67 as template. The PCR fragment was 59-end labelled with [c-32 P]ATP using T4 polynucleotide kinase (MBI) and purified using the QIAquick Nucleotide Removal Kit (Qiagen). The recombinant BvgA proteins were diluted in 16 dilution buffer (2 mM MgCl 2 , 50 mM KCl, 0?1 % Igepal CA 630, 10 mM DTT) and were phosphorylated by incubation with 50 mM acetyl phosphate (Sigma) for 20 min at room temperature. Increasing amounts of the proteins were added to approximately 15 000 c.p.m. of the labelled DNA probe in 20 ml of 16 binding buffer (10 mM Tris/HCl, pH 8, 10 mM KCl, 5 mM EDTA, 1 mM DTT, 10 % glycerol, v/v). The samples were incubated for 20 min at room temperature and were then loaded onto a nondenaturing 4 % polyacrylamide gel (Sambrook & Russell, 2000) . Gels were run for 2?5 h at 150 V and subsequently the dried gels were autoradiographed.
DNase I footprinting. DNase I footprint experiments were performed essentially as described by Dickneite et al. (1998) . A 253 bp DNA fragment containing part of the upstream region of the bvgAS BH locus was PCR amplified from chromosomal DNA of B. holmesii G7702 using primer pair FP1-3/FP1-5. The purified promoter fragment was cloned into plasmid pGEM-T. The resulting plasmid pGEM-T-FP was digested with BamHI and 59-end labelled with [c-32 P]ATP using T4 polynucleotide kinase. The labelled promoter fragment was excised from the plasmid by KpnI digestion, purified by gel electrophoresis and eluted in 3 ml elution buffer (10 mM Tris/HCl, pH 8?0, 1 mM EDTA, 300 mM sodium acetate, 0?2 % SDS). The eluted probe was then extracted with phenol/ chloroform (1 : 1, v/v) and ethanol precipitated. Binding reaction mixtures contained various concentrations of protein and approximately 100 000 c.p.m. of labelled DNA probe in 50 ml of 16 binding buffer (10 mM Tris/HCl, pH 8, 2 mM MgCl 2 , 0?1 mM CaCl 2 , 1 mM DTT, 10 % glycerol, v/v). The samples were incubated for 20 min at room temperature and then the nucleolytic reactions were initiated by the addition of 1 U DNase I in 16 binding buffer. After 1 min, digestions were terminated by the addition of 140 ml stop buffer (192 mM sodium acetate, 0?14 % SDS, 62 mg ml (1 : 1, v/v), ethanol precipitated and run on a 6 % polyacrylamideurea sequencing gel. A G+C sequence reaction was also conducted in parallel with the labelled DNA probe (Maxam & Gilbert, 1977) and electrophoresed on the same gel.
RESULTS
Characterization of the bvgAS loci of the 'new' Bordetella species
To clone the bvgA genes of B. holmesii (BH), B. hinzii (BHZ) and B. trematum (BT), a PCR approach, with degenerate primers deduced from highly conserved regions of the receiver domain and from the output domain of BvgA from B. pertussis (BP), was used. The obtained DNA fragments of 285 or 237 bp were used as probes to screen partial genomic libraries of the respective organisms or were extended by genome walking. Assembly of the resulting DNA sequences yielded the entire bvgAS locus, and 873 bp and 1373 bp from its upstream and downstream regions in the case of B. holmesii. In the case of B. trematum, 1068 bp from the upstream region of the bvgAS locus, and 3142 bp encoding BvgA and the N-terminal 839 amino acids of BvgS were obtained. From the B. hinzii bvgAS locus, a partial sequence, comprising a fragment encoding the N-terminal 166 amino acids of BvgA and 660 bp from the upstream region, was determined.
The genome organization of the bvgAS loci of the 'new' Bordetella species differs from that of the members of the B. bronchiseptica cluster. In B. holmesii, B. hinzii and B. trematum, a gene (orfX) encoding a putative response regulator was detected at a distance of about 400 bp upstream from bvgA in the same transcriptional direction, while in the members of the B. bronchiseptica cluster the fhaB gene encoding filamentous haemagglutinin (FhaB) is located upstream of bvgA (Parkhill et al., 2003) . Also, in B. avium, an ORF encoding a homologous response regulator was found upstream of bvgA; this ORF was annotated by Spears et al. (2003) as an orthologue of the vieA gene of V. cholerae. Furthermore, no orthologue of the bvgR gene, which is located downstream of bvgAS in the genomes of the members of the B. bronchiseptica cluster is present within the analysed region downstream of bvgAS in B. holmesii. The lack of a bvgR orthologue in the downstream region has already been described for B. avium (Spears et al., 2003) , therefore suggesting that the genome organization of the bvgAS locus is conserved in B. avium and the 'new' Bordetella species (Fig. 1) .
As was reported for B. avium (Spears et al., 2003) , the nucleotide sequences of the bvgAS genes of the 'new' Bordetella species exhibit only a low degree of similarity with the orthologous genes of the members of the B. bronchiseptica cluster, with the pairwise identity between the bvgA and bvgS sequences of B. holmesii and the orthologous genes from B. pertussis being 72?7 % and 59?9 %, respectively. However, the amino acid sequences of the BvgA proteins of B. holmesii or B. trematum and BvgA from B. pertussis are highly similar in the receiver and output domains (74?8 and 86?1 % mean pairwise identity, respectively), while the linker region connecting the two functional domains is less conserved (34?5 % pairwise identity). Similarly, the alignment of the BvgS orthologues of B. holmesii and B. pertussis showed a high similarity in the cytoplasmic transmitter, receiver and HPt domains (52?9 % identity), but much less sequence conservation in the periplasmic domain, which is believed to be involved in signal perception (39?5 % identity).
Interestingly, DNA sequence analysis of the bvgA gene of the B. holmesii type strain ATCC 51541 (bvgA BH ATCC 51541 ) revealed the insertion of an adenosine residue at nucleotide position 212 which leads to a frameshift mutation that causes the premature termination of the encoded protein. Therefore, we sequenced the bvgA BH gene of three additional B. holmesii strains which were isolated independently from each other in different geographical regions and at different times. In one of these strains, B. holmesii No1, we found the identical mutation to that seen in the type strain, while the bvgA BH genes of the other two isolates, B. holmesii G7702 and G8341, are intact. This observation is reminiscent of the phenomenon of phase variation in B. pertussis and B. bronchiseptica and, therefore subsequently in this paper B. holmesii isolates with an intact bvgA BH gene are considered as wild-type strains, while strains carrying the frameshift mutation are classified as phase variants. However, after the insertion of a kanamycinresistance cassette into the bvgA BH gene of the B. holmesii wild-type strain G7702, the resulting bvgA BH mutant strain B. holmesii G7702/bvgA BH : : kan displayed growth behaviour and colony morphology indistinguishable from its parent strain and from the other B. holmesii strains mentioned above.
The cytoplasmic signalling domains of BvgS BH and BvgS BP are functionally interchangeable It has been shown already that the bvgAS loci of B. pertussis and B. bronchiseptica can replace each other in vivo Martinez de Tejada et al., 1996) . To investigate whether the bvgAS BH genes of B. holmesii are able to functionally complement B. pertussis bvgAS mutants, we introduced plasmid pRK-bvgAS BH G7702 , containing the orfX-bvgAS intergenic region and the entire bvgAS locus of B. holmesii G7702 (bvgAS BH G7702 ) into the B. pertussis strains 359 and 347 by conjugation. BP 359 contains a polar Tn5 insertion in the bvgA BP gene and is therefore unable to express both the BvgA BP and the BvgS BP proteins. In BP 347, the bvgS BP gene is disrupted, resulting in the low-level expression of BvgA BP due to the presence of a weak constitutive promoter upstream of bvgAS BP ; however, BvgA BP is present in its non-phosphorylated and therefore inactive state (Fig. 2a) .
Expression of the B. holmesii bvgAS BH locus in BP 359(pRKbvgAS BH G7702 ) was proven by RT-PCR experiments and Western blotting with a BvgA BH -specific polyclonal antibody which also recognizes BvgA BP (data not shown). BP 359(pRK-bvgAS BH G7702 ) and BP 347(pRK-bvgAS BH G7702 ) were compared with the positive control strains BP 347(pLA57vir) and BP 359(pLA57vir), which are complemented with the wild-type bvgAS BP locus for the ability to express the virulence determinants FhaB and Cya (adenylate cyclase toxin). Strain BP 347(pRK-bvgAS BH G7702 ) but not BP 359(pRK-bvgAS BH G7702 ) formed small haemolytic colonies on BG-blood agar plates and produced FhaB, as determined by immunoblot analysis (Fig. 2b) . The failure of strain BP 359(pRK-bvgAS BH G7702 ) to activate fhaB transcription was also confirmed by primer extension experiments with an fhaB-specific oligonucleotide primer and RNA prepared from BP 359(pRK-bvgAS BH G7702 ) (data not shown). These data suggest that, despite the high degree of sequence similarity, BvgA BH can not functionally substitute for BvgA BP in B. pertussis in vivo, while BvgS BH can replace BvgS BP in the phosphorylation of BvgA BP .
To confirm that the successful complementation in BP 347(pRK-bvgAS BH G7702 ) was due to cross-phosphorylation between BvgS BH and BvgA BP , plasmid pRK-bvgAS BH ATCC 51541 , carrying the bvgAS BH locus of the bvgA phase variant B. holmesii ATCC 51541, was introduced into BP 347 by conjugation. As expected, the resulting strain BP 347(pRKbvgAS BH ATCC 51541 ) was haemolytic on BG blood agar plates and expressed FhaB (data not shown). In keeping with these results, efficient cross-phosphorylation between the purified BvgS BP and BvgA BH proteins was also observed in vitro (data not shown).
Since it is well known that high concentrations of MgSO 4 inhibit the histidine kinase activity of BvgS BP (Melton & Weiss, 1989) , strain BP 347(pRK-bvgAS BH ATCC 51541 ) was analysed for the activity of histidine kinase BvgS BH in the presence of MgSO 4 . The effect of MgSO 4 on the phosphorylation status of BvgS BH ATCC 51541 , and consequently on the expression of the virulence genes, was investigated by primer extension experiments using the fhaB-specific primer and RNA extracted from BP 347(pRK-bvgAS BH ATCC 51541 ) cells cultured in the presence or absence of 50 mM MgSO 4 . As shown in Fig. 2(c) , addition of MgSO 4 to the culture medium completely repressed fhaB transcription in the positive control strain BP 347(pLA57vir), while transcription of fhaB was only slightly reduced under these growth conditions in BP 347(pRK-bvgAS BH ATCC 51541 ).
Taken together these data demonstrate that the cytoplasmic signalling domains of BvgS BP and BvgS BH are functionally interchangeable, while differences exist regarding the function of their N-terminal signal-perception domains.
BvgA BH binds in vitro to the orfX-bvgAS BH intergenic region but not to the BvgA BP binding site of the fhaB promoter of B. pertussis
The results of the complementation experiments suggest that the failure of plasmid pRK415-bvgAS BH G7702 to restore virulence gene expression in the B. pertussis mutant BP 359 is due to the inability of BvgA BH to bind to the fhaB and cya promoters. Therefore, we investigated, by gel retardation experiments, the in vitro binding of BvgA BH to a 77 bp DNA fragment containing the well-characterized BvgA BP binding site of the promoter region of the B. pertussis fhaB gene. A clear band shift of the fhaB probe was observed with the purified BvgA of B. pertussis, irrespective of whether the protein was in vitro phosphorylated with acetyl phosphate prior to the binding assay, as has been described by Zu et al. (1996) (Fig. 3b) . In contrast, no binding to the fhaB promoter fragment could be detected with either the unphosphorylated or the phosphorylated BvgA BH protein (Fig. 3a) , suggesting that BvgA of B. holmesii is unable to recognize canonical BvgA BP -dependent promoters. In keeping with this hypothesis, we could not detect binding of BvgA BH to the bvgA BP promoter region in gel retardation experiments (data not shown).
As transcription of the bvgAS locus is autoregulated in the members of the B. bronchiseptica cluster (Scarlato et al., 1990; Karimova & Ullmann, 1997) , we analysed whether BvgA BH is able to bind the intergenic region between orfX and bvgAS BH in B. holmesii. DNase I footprint experiments, with increasing amounts of BvgA BH , were performed on a cloned 253 bp DNA segment spanning from nucleotide position +20 to 2232 with respect to the translational start site of bvgA BH . Addition of 180 ng in vitro-phosphorylated BvgA BH (BvgA BH -P) resulted in a region of DNase I protection ranging from position 270 to 2195 with respect to the start codon of bvgA BH , with the appearance of a regular pattern of hypersensitive sites every 10 to 11 nucleotides (Fig. 4) . No further extension of the protected region was observed upon the addition of higher amounts of BvgA BH -P. This was tested by using additional overlapping DNA probes covering an entire region ranging from position +81 to 2313 with respect to the bvgA BH start codon (data not shown). Binding of unphosphorylated BvgA BH to the bvgAS BH promoter probe could not be detected (Fig. 4) . Interestingly, a virtually identical binding pattern was observed when in vitro-phosphorylated BvgA from B. pertussis was added to the bvgAS BH promoter probe (data not shown). As in the case of BvgA BH , unphosphorylated BvgA BP was unable to bind to the bvgAS BH promoter region (data not shown).
Careful in silico analysis of the 125 bp region which is protected from DNase I digestion in the orfX-bvgAS BH intergenic region revealed the presence of four 14 bp sequence motifs (IR1-IR4) which are arranged at a regular spacing of 20-21 bp from each other. These sequence motifs bear a certain resemblance to the consensus heptanucleotide inverted-repeat sequence which constitutes the primary binding site for BvgA BP in BvgA BP -dependent B. (pLA57vir) and BP 347(pRK-bvgAS BH ATCC 51541 ) grown under modulating conditions. Primer extension experiments, with the fhaB-specific oligonucleotide fhaB-PE, were performed on equal amounts of RNA extracted from BP 347 (lane 1) and BP 347(pLA57vir) (lanes 2 and 3) and BP 347(pRK-bvgAS BH ATCC 51541 ) (lanes 4 and 5) which had, for lanes 3 and 5, been grown in the presence of 50 mM MgSO 4 . The arrow indicates the fhaB-specific cDNA.
pertussis promoters, as one half site of each sequence motif matches the BvgA BP consensus half site motif in six (IR1, IR2), or four (IR3, IR4) out of seven positions (Fig. 5) . The second half site, however, does not show significant similarity to the BvgA BP consensus binding site. Therefore, the 14 bp sequence motifs, which all exhibit similar binding affinities for BvgA BH at least under the conditions of in vitro DNA binding, might represent the primary binding sites of BvgA BH in the orfX-bvgAS BH intergenic region.
Taken together, the results on the binding of BvgA BH to the orfX-bvgAS BH intergenic region suggest an autoregulatory role for BvgA BH in the expression of the BvgAS twocomponent system of B. holmesii.
BvgA BH activates transcription of the bvgAS BH locus in B. holmesii
To analyse whether the bvgAS locus of B. holmesii is autoregulated, primer extension experiments were performed with RNA extracted from B. holmesii strain G7702 and the isogenic bvgA knockout mutant G7702/bvgA BH : : kan, using a bvgA BH -specific oligonucleotide. As shown in Fig. 6(a) , two transcriptional start sites could be identified at positions 220 (S1) and 234 (S2) with respect to the translational start codon of bvgA BH . Upstream of both start sites, putative 210 regions are present which exhibit one (P2: CATAAT) and two (P1: TAAAAC) mismatches compared to the 210 consensus promoter element of E. coli. These putative 210 elements are located at a distance of 27 and 42 bp, respectively, from the IR1 sequence motif, within the region which is protected from DNase I digestion Fig. 3 . Binding of BvgA BH and BvgA BP to the BvgA BP binding site of the B. pertussis fhaB promoter. (a) A radiolabelled 77 bp PCR fragment containing the BvgA BP binding site of the fhaB promoter of B. pertussis was incubated with 80, 160, 240, 360 and 600 ng of purified BvgA BH which was phosphorylated in vitro (lanes 2-6) and with unphosphorylated BvgA BH (lanes 7-11), respectively. (b) The same radiolabelled fhaB promoter fragment was incubated with 80, 160, 240, 360 and 600 ng of in vitro phosphorylated (lanes 2-6) and unphosphorylated (lanes 7-11) BvgA BP , respectively. Lane 1 on both panels contains the radiolabelled DNA probe. The reaction mixtures were run on a non-denaturing 4 % polyacrylamide gel. F, free DNA; C, DNA-protein complex. Fig. 4 . Binding of BvgA BH to the intergenic region between orfX and bvgAS BH . DNase I footprint experiments were performed on a 253 bp BamHI-KpnI DNA fragment from plasmid pGEM-T-FP labelled at its BamHI site. The 59-labelled probe was incubated with 180, 360 and 600 ng in vitrophosphorylated BvgA BH (BvgA BH -P; lanes 3-5, respectively) or the same amounts of unphosphorylated BvgA BH (lanes 6-8, respectively) . No protein was added to the reaction mixture loaded in lane 2. Lane 1 is a G+A sequencing reaction on the DNA probe used as a size marker (Maxam & Gilbert, 1977) . Numbers on the left indicate the distance from the translational start codon of bvgA BH . The vertical bar on the right indicates the area of DNase I protection.
in the footprint experiments performed with BvgA BH (Fig. 5) . The amount of bvgA BH -specific transcript was clearly reduced in G7702/bvgA BH : : kan, suggesting a positive autoregulatory effect of BvgA BH on the transcription of bvgAS BH in B. holmesii. To confirm these results, a DNA fragment comprising 455 bp of the 59 region of bvgAS BH was fused to a promoterless gfp gene in the broad-hostrange vector pMMB208 and the resulting plasmid pMMBbvgAS BH up-gfp was conjugated into B. holmesii G7702 and G7702/bvgA BH : : kan. Expression of the reporter gene was investigated by immunoblot analysis using a polyclonal antibody directed against GFP. Consistent with the results of the primer extension experiments, expression of the gfp reporter gene was clearly reduced in the bvgA mutant G7702/bvgA BH : : kan as compared to the wild-type strain G7702 (Fig. 6b) , corroborating positive autoregulation by BvgA BH .
The pMMB-bvgAS BH up-gfp reporter plasmid was also introduced into the B. pertussis strains Tohama I (TI), BP 347 and BP 359. Expression of GFP was hardly detectable by immunoblot analysis in the wild-type strain TI(pMMBbvgAS BH up-gfp), while strong expression of the reporter gene was observed in the bvgAS mutant BP 359(pMMBbvgAS BH up-gfp). Mutant BP 347(pMMB-bvgAS BH up-gfp), harbouring a Tn5 insertion in the bvgS BP gene and therefore expressing unphosphorylated BvgA BP , produced a significantly lower amount of GFP than BP 359(pMMBbvgAS BH up-gfp) (Fig. 7a) . In contrast to the positive autoregulation exerted by BvgA BH in B. holmesii, these data suggest that binding of BvgA BP to the bvgAS BH promoter region represses the transcription of the gfp reporter gene in B. pertussis. Primer extension analysis performed with RNA extracted from BP 359(pMMBbvgAS BH up-gfp) using a gfp-specific oligonucleotide demonstrated that transcription of gfp starts at position 2139 with respect to the translational start codon of bvgA BH (Fig. 7b) . This transcriptional start site corresponds to a promoter which is different from the promoters directing transcription of bvgAS BH in B. holmesii and which is located within the region protected in DNase I footprint experiments by the BvgA BP protein on the bvgAS BH promoter probe. The putative 210 (TATGCT) and 235 (TATTCA) boxes of this promoter differ in two and three positions, respectively, from the E. coli 210 and 235 consensus promoter elements. Therefore, it seems likely that binding of BvgA BP to the bvgAS BH promoter region in B. pertussis interferes with the binding of the RNA polymerase to this B. pertussisspecific promoter located in the bvgAS BH upstream region. Interestingly, a transcriptional start site differing only slightly (position 2130) from the one used in B. pertussis is observed when transcription of the bvgAS BH -gfp promoter fusion is analysed in E. coli (data not shown).
DISCUSSION
The regulatory BvgAS two-component system is the master regulator of virulence gene expression in the members of Transcriptional start sites of the BvgA BH -dependent promoters P1 (S1) and P2 (S2) of bvgA BH are marked by arrows. Putative "10 promoter elements are boxed. The region protected from DNase I digestion in footprint experiments with BvgA BH -P is highlighted by grey shading. The 14 bp sequence motifs showing similarity to the inverted-repeat sequence representing the consensus BvgA BP binding site (IR1-IR4) are indicated by horizontal arrows within the double-stranded DNA sequence, and the high-scoring half-site of each sequence motif is highlighted by bold letters in the nucleotide sequence. The distances between the IR1-IR4 motifs are indicated above the sequence. The broken arrow marked S P indicates the transcriptional start site of gfp transcribed from the bvgAS BH up-gfp promoter fusion in BP 359(pMMB-bvgAS BH up-gfp). The "10 element of the corresponding putative promoter is also boxed. the B. bronchiseptica cluster which cause respiratory tract infections in man and other mammals, and has been demonstrated to play a critical role in the establishment and maintenance of disease (Cotter & DiRita, 2000; . Since the 'new' members of the genus Bordetella, in particular B. holmesii, are increasingly recognized to be associated with human diseases, we set out to clone putative orthologues of the bvgAS genes of these bacteria as a first approach to characterize their pathogenic potential.
By PCR with degenerate oligonucleotide primers derived from the BvgA sequence of B. pertussis, we obtained bvgAspecific DNA fragments from the three organisms; these fragments were used as probes for the cloning of the complete bvgAS locus from B. holmesii and of partial sequences of bvgAS from B. trematum and B. hinzii. At the DNA level, the bvgAS genes of the three 'new' Bordetella species show only limited sequence similarity with their orthologues from the members of the B. bronchiseptica cluster, explaining our previous failure to prove their presence by DNA hybridization experiments with B. pertussis-specific DNAprobes (Gerlach et al., 2001) . However, as far as they were determined, the deduced amino acid sequences of BvgAS were found to be conserved between all species including the bird pathogen B. avium whose bvgAS genes have recently been cloned (Spears et al., 2003) . As expected, sequence similarity is highest in the two-component signalling modules but is less pronounced in the recently characterized linker region of BvgA ) and the sensory domain of BvgS. Clearly the BvgAS proteins of the 'new' Bordetella species and of B. avium are more closely related to each other than to the orthologous proteins of the members of the B. bronchiseptica cluster (Table 3) .
Similarly, the genomic organization of the bvgAS loci of the 'new' Bordetella species and of B. avium seems to be identical, but differs from the members of the B. bronchiseptica cluster. In the 'new' Bordetella species and in B. avium, a gene (orfX) encoding a putative response regulator protein was observed upstream of bvgAS, and downstream no orthologue of the gene encoding the BvgR protein, which is involved in regulating the virulence repressed genes (vrg) in the members of the B. bronchiseptica cluster, is present in B. holmesii and B. avium (Fig. 1) . The upstream regulator is also present in B. bronchiseptica and B. parapertussis, although at a different location on the chromosome, while it is missing in B. pertussis. Unexpectedly, 16S rDNA sequence analysis had suggested that the closest phylogenetic relationship was between B. pertussis and B. holmesii (Weyant et al., 1995; Gerlach et al., 2001) ; however, in agreement with comparisons of the amino acid sequences of conserved proteins (von Wintzingerode et al., 2002) , our characterization of the bvgAS loci clearly classifies B. holmesii as proximate to the species B. avium, B. hinzii and B. trematum.
Interestingly, the bvgA sequences of two out of four independent clinical isolates of B. holmesii contained an identical point mutation causing a frameshift that results in the premature termination of the encoded protein. This is reminiscent of phase variation in B. pertussis and B. bronchiseptica leading to the loss of virulence properties upon in vitro passaging of the respective strains due to mutations in the bvgS genes Stibitz et al., 1989) . However, phase variants of these organisms have apparently never been isolated from infected hosts. Since inactivation of the bvgA gene in B. holmesii G7702 had no obvious effect on growth and colony morphology of the mutant, the possibility that frameshift mutations in strains ATCC 51541 and No1 occurred after their isolation from the infected patients can not be ruled out. But, since the site of the mutation is not associated with a homo-or dinucleotide tract which could cause slipped-strand mispairing, it seems rather unlikely that the identical insertion mutation should have occurred in both strains as a consequence of in vitro culture. The apparent isolation of bvgA mutants from infected individuals would clearly argue against a role of the BvgAS BH two-component system in the regulation of important virulence traits in B. holmesii, while inactivation of bvgAS BA caused a clear attenuation of the virulence of B. avium in turkey poults (Spears et al., 2003) . Interestingly, Njamkepo et al. (2000) reported differences in the protein hybridization patterns of different B. holmesii isolates, including the type strain, ATCC 51541, and G7702, when the bacterial lysates were probed with sera from infected individuals, and therefore they suggested that the phenomenon of phase variation might exist in B. holmesii. However, the observed differences in the protein patterns do not correlate with the presence or absence of a functional BvgA BH protein as predicted by our sequence analysis of the same strains.
The observation that the bvgAS BH locus is able to restore virulence gene expression in the B. pertussis bvgS mutant BP 347 but not in the bvgAS mutant BP 359 suggested crossphosphorylation between the BvgS BH histidine kinase and BvgA BP (Fig. 2) . Similarly, cross-phosphorylation was also demonstrated to occur between BvgS BP and BvgA BH in vitro (data not shown). Therefore, the cytoplasmic signalling domains of BvgS BH and BvgS BP , showing 52?9 % identity, are functionally interchangeable in the recognition of the orthologous BvgA response regulator proteins, whose receiver domains are 76?2 % identical. In the genetic background of BP 347, BvgS BH is only slightly responsive to the presence of 50 mM MgSO 4 , which causes phenotypic modulation in the wild-type B. pertussis strain TI. Therefore, in accordance with the observation that the periplasmic input domains of BvgS BH and BvgS BP show a far lower degree of similarity (39?5 % identity) than the cytoplasmic domains, signal perception of the BvgS proteins from B. holmesii and B. pertussis seems to be different. Similarly, in the genetic background of B. bronchiseptica, the function of the BvgS BP protein was indistinguishable from BvgS BB when the expression of virulence factors, under either standard in vitro culture conditions or in vivo growth in an animal model, was investigated, but the sensitivity to modulating agents in vitro was different between BvgS BB and BvgS BP (Martinez de Tejada et al., 1996) . BvgS BB and BvgS BP are highly similar (87 % overall identity), but, as seen with BvgS BH and BvgS BP , most of the non-conservative amino (Boucher et al., 2001 . These secondary binding sites show a very limited degree of similarity to the high-affinity heptanucleotide inverted-repeat motif, but binding of BvgA BP -P to the low-affinity binding sites is required for full transcriptional activation of the fhaB promoter (Boucher et al., 1997 (Boucher et al., , 2001 ).
Similarly, the ptx promoter harbours two inverted heptad repeats in the region ranging from position 2167 to 2123 relative to the transcriptional start site. These repeats match the fhaB high-affinity binding motif in five of seven positions, and cooperative binding of multiple BvgA BP -P dimers to the DNA downstream of these primary binding sites is necessary for the activation of ptx transcription (Boucher & Stibitz, 1995; Marques & Carbonetti, 1997) . Differences in the affinity of the BvgA BP binding sites in the fhaB and ptx promoters, resulting in the requirement of higher concentrations of BvgA BP -P for transcriptional activation of ptx, account for the different temporal pattern of expression of these virulence genes ). Here we demonstrate that in B. holmesii transcription of bvgAS BH is under control of two overlapping promoters which are positively regulated by BvgA BH , since transcription of bvgAS BH and expression of a gfp reporter gene which was fused to the bvgAS BH promoter region were reduced in the bvgA BH mutant G7702/bvgA BH : : kan (Fig. 6) . However, basal BvgA BH -independent transcription from these promoters was also detected in G7702/ bvgA BH : : kan, and this might be responsible for low-level expression of BvgAS BH under conditions in which the BvgS BH histidine kinase is inactive. The moderate difference in the amount of bvgAS BH transcript in strains G7702 and G7702/bvgA BH : : kan might indicate that, in contrast to BvgS BP , BvgS BH is not fully activated under the standard in vitro culture conditions tested so far.
Interestingly, the region upstream of the regulated bvgAS BH promoters, which is protected in DNase I footprint experiments with in vitro-phosphorylated BvgA BH , contains four 14 bp sequence motifs (IR1-IR4) in a regular spacing of 20-21 bp, which show similarity to the heptanucleotide inverted-repeat sequence that has been deduced as consensus motif for the primary binding site for BvgA BP in BvgA BP -dependent B. pertussis promoters (Fig. 5 ). This arrangement of binding sites might suggest end-to-end binding of BvgA BH dimers to the same face of the DNA helix. The sequence motifs IR1 and IR2, showing the highest degree of similarity to the BvgA BP consensus half-site motif T/A-T-T-C-C/T-T-A, are located proximal to the transcriptional start site of bvgAS BH , while IR3 and IR4, which match the sequence of the consensus binding site in four of seven positions, are located further upstream. This architecture of putative high-and low-affinity BvgA BH binding sites differs from the fhaB and ptx promoters, but resembles the B. pertussis core bvgR promoter, which, for activity, requires binding of BvgA BP -P to a secondary binding site located at a distance of 22 bp upstream from the primary binding site, which is centred at position 253?5 proximal to the transcriptional start site. Interestingly, the BvgA BP binding motifs in the bvgR promoter also consist of one half-site with high-scoring similarity to the BvgA BP consensus binding motif in combination with a low-scoring half-site (Merkel et al., 2003) . However, DNase I footprint experiments did not provide indications for differences in the binding affinities of sequence motifs IR1-IR4 in the bvgAS BH promoter since a sharp onset of protection, spanning the complete region from position 270 to 2195 relative to the bvgA BH start codon, was observed upon addition of low amounts of BvgA BH . Considering the striking similarity of the bvgAS BH promoter region to BvgA-dependent promoters of B. pertussis and the fact that in vitro binding of BvgA BP -P to this promoter is virtually indistinguishable from BvgA BH -P, the inability of BvgA BH to interact with B. pertussis promoters remains unexplained.
In the B. pertussis bvgAS mutant BP 359 containing the bvgAS BH up-gfp promoter fusion, transcription of the gfp reporter gene is directed from a promoter different to the overlapping P1 and P2 promoters in B. holmesii. Transcription from this promoter starts within the region of BvgA BH -and BvgA BP -binding, unless the detected transcript is the defined processing product of a longer mRNA transcribed from a cryptic promoter located further upstream or in the plasmid backbone (Fig. 5, Fig. 7 ). In the B. pertussis wild-type strain TI, BvgA BP -P does not stimulate transcription from the overlapping BvgA BH -dependent P1 and P2 promoters, but instead binding of BvgA BP -P to the upstream region of bvgAS BH seems to interfere with transcription from the alternative promoter since no expression of the gfp reporter gene could be detected in TI(pMMB-bvgAS BH up-gfp). Although in vitro binding of unphosphorylated BvgA BP to the bvgAS BH promoter region was not observed, expression of gfp was also strongly reduced in the bvgS mutant BP 347(pMMB-bvgAS BH up-gfp) as compared to BP 359(pMMB-bvgAS BH up-gfp) (Fig. 7) . It should be noted that despite the inhibitory effect of BvgA BP on transcription from the bvgAS BH upstream region in B. pertussis, low-level expression of BvgS BH was sufficient to restore virulence gene expression in BP 347(pRK-bvgAS BH G7702 ). We are currently trying to identify the members of the BvgA regulon of B. holmesii. The characterization of additional BvgA BH -dependent promoters will help to unravel the molecular basis of the striking differences in promoter recognition observed with the highly homologous BvgA proteins of B. holmesii and B. pertussis.
